Showing results (121-130 of 198) with videos related to

Sort By:
Pageof 20
Plos One|January 26, 2019
A new formula to calculate the resection limit in hepatectomy based on Gd-EOB-DTPA-enhanced magnetic resonance imagingShinichiro Yamada, Mitsuo Shimada, Yuji Morine, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 3, 2015
Liver regeneration after splenectomy in patients with liver cirrhosisShinichiro Yamada, Yuji Morine, Satoru Imura, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|July 13, 2016
Role of thrombospondin-1 expression in colorectal liver metastasis and its molecular mechanismHiroki Teraoku, Yuji Morine, Tetsuya Ikemoto, et al.
Hepato-Gastroenterology|July 16, 2015
Carcinogenic Potential of Biliary Epithelium of Congenital Choledochal Cyst Model in Rats: A Special Reference to HDAC ExpressionHisako Kuyama, Yuji Morine, Mitsuo Shimada, et al.
The Journal of Medical Investigation : JMI|September 21, 2016
Complication of portal vein thrombosis after right hemihepatectomy in a patient lacking the portal vein bifurcationHiroki Teraoku, Yusuke Arakawa, Masato Yoshikawa, et al.
Applied Microbiology and Biotechnology|November 10, 2006
Effective cellulose production by a coculture of Gluconacetobacter xylinus and Lactobacillus maliAkira Seto, Yu Saito, Mayumi Matsushige, et al.
International Journal of Clinical Oncology|May 11, 2011
Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cellsShuichi Iwahashi, Mitsuo Shimada, Tohru Utsunomiya, et al.
World Journal of Surgery|March 11, 2020
Role of Central Hypo-enhancement in the Hepatic Arterial Phase of Dynamic Computed Tomography in Patients with Mass-Forming Intrahepatic CholangiocarcinomaHiroki Teraoku, Yuji Morine, Naoto Uyama, et al.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Oligomeric Proanthocyanidins Reverse Lenvatinib Resistance in Hepatocellular Carcinoma Through ITGA3-Mediated PathwayTakayuki Noma, Yuan Li, Yuma Wada, et al.
Cancer Science|June 23, 2021
The BAFF/NFκB axis is crucial to interactions between sorafenib-resistant HCC cells and cancer-associated fibroblastsLuping Gao, Yuji Morine, Shinichiro Yamada, et al.
Pageof 20